 Home > Biochemistry News > Biotechnology News > FDA accelerates approval of the first achondroplasia treatment for the root cause of the disease

FDA accelerates approval of the first achondroplasia treatment for the root cause of the disease

 Last Update: 2021-12-02
 Source: Internet
 Author: User

Tags

lupride injection

boniva injection

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

On November 19, 2021, BioMarin Pharmaceutical announced that the U.

Achondroplasia is mainly manifested by the slow growth of the bones at the base of the limbs, spine and skull.

Its pathogenesis is due to mutations in the gene encoding fibroblast growth factor receptor 3 (FGFR3), resulting in overactive FGFR3 protein

▲In the process of normal bone growth, chondrocytes will continue to form new bones on the growth plate

This approval is based on the positive results of a phase 3 clinical trial and its open-label extension study

"Chondroplasia is a lifelong genetic disease caused by bone structural disorders caused by impaired

Reference materials:

[1] BioMarin Receives FDA Approval for VOXZOGO™ (vosoritide) for Injection, Indicated to Increase Linear Growth in Children with Achondroplasia Aged 5 and Up with Open Growth Plates.

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.